Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 349Neoplasms 315Carcinoma, Non-Small-Cell Lung 277Prostatic Neoplasms 221Colorectal Neoplasms 208Lung Neoplasms 177Multiple Myeloma 149Ovarian Neoplasms 136Pancreatic Neoplasms 130Neoplasm Metastasis 123Leukemia, Myeloid, Acute 121Melanoma 104Squamous Cell Carcinoma of Head and Neck 90Recurrence 84Lymphoma 84Carcinoma, Renal Cell 84Lymphoma, Non-Hodgkin 82Endometrial Neoplasms 82Stomach Neoplasms 80Brain Neoplasms 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Carcinoma, Hepatocellular 77Head and Neck Neoplasms 71Glioma 70Glioblastoma 70Uterine Cervical Neoplasms 67Urinary Bladder Neoplasms 65Leukemia, Lymphocytic, Chronic, B-Cell 65Sarcoma 63Hematologic Neoplasms 62

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthritis, Reactive × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡